Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2010 1
2018 1
2019 2
2020 5
2021 4
2022 4
2023 3
2024 3
2025 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial.
Nicholls SJ, Ryan DH, Deanfield J, Ferreira D, Lang CC, Lincoff AM, Lingvay I, Lübker C, Terns PP, Rasmussen S, Stensen S, Weeke PE, Kahn SE; SELECT Trial Investigators. Nicholls SJ, et al. JAMA Cardiol. 2026 Feb 1;11(2):156-164. doi: 10.1001/jamacardio.2025.4824. JAMA Cardiol. 2026. PMID: 41433034 Free PMC article. Clinical Trial.
GLP-1R Agonists Improve Ocular Surface Parameters in Type 2 Diabetes Mellitus.
Ottonelli G, Gaeta A, Montericcio N, Tredici C, Ortfeldt V, Birtolo MF, Jaafar S, Mirani M, Di Maria A. Ottonelli G, et al. Among authors: mirani m. Clin Ophthalmol. 2025 Oct 15;19:3829-3836. doi: 10.2147/OPTH.S547776. eCollection 2025. Clin Ophthalmol. 2025. PMID: 41116973 Free PMC article.
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, Lingvay I, Colhoun HM, Plutzky J, Kosiborod MN, Hovingh GK, Hardt-Lindberg S, Frenkel O, Weeke PE, Rasmussen S, Goudev A, Lang CC, Urina-Triana M, Pietilä M, Lincoff AM; SELECT Trial Investigators. Deanfield J, et al. Lancet. 2024 Aug 24;404(10454):773-786. doi: 10.1016/S0140-6736(24)01498-3. Lancet. 2024. PMID: 39181597 Free article. Clinical Trial.
COVID-19 vaccines and blood glucose control: Friend or foe?
Vena W, Pigni S, Betella N, Navarra A, Mirani M, Mazziotti G, Lania AG, Bossi AC. Vena W, et al. Among authors: mirani m. Hum Vaccin Immunother. 2024 Dec 31;20(1):2363068. doi: 10.1080/21645515.2024.2363068. Epub 2024 Jun 11. Hum Vaccin Immunother. 2024. PMID: 38860457 Free PMC article. Review.
28 results